financetom
Business
financetom
/
Business
/
Chilean authorities have opened probe into accident at Albemarle lithium plant, lawmaker says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chilean authorities have opened probe into accident at Albemarle lithium plant, lawmaker says
Aug 12, 2025 8:10 AM

SANTIAGO, Aug 12 (Reuters) - Chilean authorities have

opened an investigation into Albemarle's La Negra lithium

processing plant following an accident reported last week, a

local lawmaker told Reuters on Tuesday.

Lawmaker Jaime Araya, who represents the Antofagasta region

where the plant is located, said he asked Chile's mining

regulator and labor office to inspect the site last week after

receiving a complaint that a pipe containing acid had burst.

Araya said he has been informed that the labor inspector's

office had opened an investigation. A union leader for plant

workers, Elias Torres, said he could not comment because an

investigation was underway.

The labor inspector's office said it could not provide

information because the matter was under review. Albemarle did

not immediately respond to questions about whether any

operations had been suspended.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Don't write off Nike, says Britain's JD Sports
Don't write off Nike, says Britain's JD Sports
Jul 30, 2024
LONDON (Reuters) - British sports and fashion retailer JD Sports, one of Nike's largest customers, gave the world's biggest sports brand by revenue a vote of confidence on Tuesday, with a senior executive saying it will be just fine. Late last month, Nike's shares plummeted after the group warned its sales would fall this year, hurt by faltering demand for...
ZYUS Life Sciences Receives
ZYUS Life Sciences Receives "No Objection Letter" from Health Canada for Trichomylin Trial
Jul 30, 2024
09:26 AM EDT, 07/30/2024 (MT Newswires) -- ZYUS Life Sciences ( ZLSCF ) , which is developing cannabinoid-based pharmaceutical drug candidates for pain management, on Tuesday said it has received a No Objection Letter (NOL) from Health Canada for a proof-of-concept (POC) trial for its lead drug candidate, Trichomylin softgel capsules. The POC trial aims to assess the preliminary efficacy...
Arvinas' Q2 Net Loss Narrows as Revenue Rises; Names Andrew Saik CFO
Arvinas' Q2 Net Loss Narrows as Revenue Rises; Names Andrew Saik CFO
Jul 30, 2024
09:22 AM EDT, 07/30/2024 (MT Newswires) -- Arvinas ( ARVN ) reported a Q2 net loss Tuesday of $0.49 per share, narrowing from a loss of $1.25 a year earlier. Analysts polled by Capital IQ expected a loss of $0.58 per share. Revenue for the quarter ended June 30 was $76.5 million, up from $54.5 million a year earlier. Analysts...
TriMas' Q2 Adjusted Earnings Fall, Net Sales Rise; 2024 Guidance Lowered
TriMas' Q2 Adjusted Earnings Fall, Net Sales Rise; 2024 Guidance Lowered
Jul 30, 2024
09:18 AM EDT, 07/30/2024 (MT Newswires) -- TriMas ( TRS ) reported Q2 adjusted earnings Tuesday of $0.43 per diluted share, down from $0.56 a year earlier. Two analysts polled by Capital IQ expected $0.53. Net sales for the quarter ended June 30 were $240.5 million, up from $233.2 million a year earlier. The analysts polled by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved